
We developed a tumor vaccine consisting of fixed zzso zzso zzso zzso fragments, zzso zzso zzso zzso stimulating factor and zzso and an zzso The vaccine protected zzso of zzso mice from zzso cell zzso The vaccine containing human zzso zzso fragments showed essentially no adverse effect in a phase zzso clinical trial and zzso patients developed a zzso hypersensitivity zzso response against the zzso Although 2 of 4 zzso patients had recurrence after zzso zzso the zzso patients had no zzso The time before the first recurrence in the vaccinated patients was significantly longer than that in 24 historical control patients operated in the same department zzso zzso zzso This zzso is a promising candidate to prevent recurrence of human zzso 

